Thanks to its experience in the Diabetology field, Meteda has expanded its borders and has activated the National Diabetes Registry and produced the Qatar National Diabetes Registry software, in partnership with Supreme Council of Health (SCH), Hamad Medical Corporation (HMC), Qatar Diabetes Association (QDA), and Primary Health Care Corporation (PHCC), as well as with the financial support of Maersk Oil Qatar. Along with a variety of additional activities, the software was produced in the context of the Qatari Action on Diabetes project, itself part of the broader Changing Diabetes Program (promoted by the Danish pharmaceutical company Novo Nordisk).
Qatar National Diabetes Registry
The medical record for Qatari Professionals
Diabetes
Medical recordProfessionalssoftware
The Qatar National Diabetes Registry
The only tool for the collection and management of data from patients with diabetes
The Qatar National Diabetes Registry is a Web application that, for the first time, gathers data from patients with diabetes in a single national database. This registry will allow the collection and comparison of patients’ clinical data and monitoring of statistics relating to the evolution of diabetes in Qatar.
In-depth look
The Qatar National Diabetes Registry project was launched in November 2013, with the goal of creating a national database for supporting the Qatari medical authorities in their decision making vis-à-vis the diabetes care. At the same time, the database assists medical staff in managing patients with diabetes and subjects at risk. Among the many project partners, PHCC will have a crucial role in populating the Registry by collecting information from its 23 health centres disseminated across Qatar. Another key player in data collection is the Qatar Diabetes Association (QDA), whose professionals follow and educate more than 150 patients on a monthly basis. For the Qatari health system, the National Diabetes Registry is an original and innovative tool to compare and share clinical data among a variety of local healthcare bodies. The satisfactory results obtained until now have met expectations, and continue to improve day after day the ongoing treatment quality.